Vaccine expert panel suggests Duterte get Pfizer, Moderna or AstraZeneca shots

A vaccine expert panel member advised that President Rodrigo Duterte should receive a COVID-19 vaccine that has already completed Phase III clinical trials, specifically mentioning Pfizer, Moderna, and AstraZeneca.

Dr. Rontgene Solante stated that vaccines from Pfizer, Moderna, and AstraZeneca are recommended due to their completed Phase III trials.

Solante also mentioned that the Sinovac vaccine has not yet been reviewed by the panel.

Phase III trials are a crucial step before a new medical treatment can be approved, involving larger populations across different regions and countries.

Pfizer-BioNTech's vaccine completed Phase III trials in November with 95% efficacy and was the first to receive emergency use authorization in the Philippines.

Moderna's vaccine also published its Phase III trial results in November, demonstrating 94% efficacy.

AstraZeneca reported varying efficacy rates for its vaccine developed with Oxford University, and its CEO is confident in improving its effectiveness.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.